| Date Filed | Type | Description |
| 10/10/2023 |
SC 13G/A
| STATE STREET CORP reports a 2.3% stake in EXIT FILING FATE THERAPEUTICS INC |
| 08/21/2023 |
4
| Dulac Edward J III (CFO) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 4,718 shares
@ $2.8, valued at
$13.2k
|
|
| 08/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 08/07/2023 |
4
| Xu Yuan (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 632 shares
@ $3.71, valued at
$2.3k
|
|
| 08/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/06/2023 |
4
| Powl Brian T. (Chief Commercial Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 3,854 shares
@ $4.87, valued at
$18.8k
|
|
| 07/06/2023 |
4
| Dulac Edward J III (CFO) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 5,182 shares
@ $4.83, valued at
$25k
|
|
| 07/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/09/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 06/08/2023 |
4
| Redmile Group, LLC (10% Owner) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/08/2023 |
4
| Lee Michael Stewart (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/08/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/07/2023 |
4
| Xu Yuan (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/07/2023 |
4
| RASTETTER WILLIAM H (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/07/2023 |
4
| MENDLEIN JOHN (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/07/2023 |
4
| Jooss Karin (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/07/2023 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/07/2023 |
4
| EPSTEIN ROBERT S (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/07/2023 |
4
| COUGHLIN TIMOTHY (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/07/2023 |
4
| Agarwal Shefali (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 06/07/2023 |
8-K
| Other Events Interactive Data |
| 05/10/2023 |
SC 13G/A
| STATE STREET CORP reports a 14.2% stake in AMENDED FILING FATE THERAPEUTICS INC |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/21/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/21/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/19/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
8-K
| Quarterly results |
| 04/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|